(Q44338806)

2 December 2017

Antagonist-induced micro-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord (English)

1 reference

2 December 2017

0 references

Minesh Patel

1

1 reference

2 December 2017

Benedict Gomes

series ordinal

2

1 reference

2 December 2017

Chintan Patel

series ordinal

3

1 reference

2 December 2017

Byron C Yoburn

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

European Journal of Pharmacology

2 December 2017

1 reference

2 December 2017

446

1 reference

2 December 2017

1-3

1 reference

2 December 2017

37-42

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

The effect of the irreversible mu-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Differential up-regulation of microsomal and synaptic membrane mu opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

The effect of mu-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Antagonist-induced opiate receptor upregulation in cultures of fetal mouse spinal cord-ganglion explants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Morphine-activated opioid receptors elude desensitization by beta-arrestin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Chronic opioid antagonist treatment: assessment of receptor upregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Naltrexone-induced opiate receptor supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat mu-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901823-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(02)01823-X

1 reference

2 December 2017

1 reference